EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY-NC 4.0

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Min Deng iD, Shaohua Li iD, Wei Wei iD, Rongping Guo iD

Gut and Liver · 2023

DOI: 10.5009/gnl220249 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Gut and Liver, 2023. Verfasst von Min Deng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Venous Thrombosis, Antineoplastic Agents. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Although endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) and fine needle biopsy (FNB) are widely used for tissue acquisition of pancreatic solid mass, the optimal strategy of this procedure has not been established yet. The aim of this nationwide study was to investigate the current practice patterns of EUS-FNA/FNB for pancreatic solid mass in Korea.

Methods

The Policy-Quality Management of the Korean Pancreatobiliary Association (KPBA) developed a questionnaire containing 22 questions. An electronic survey consisting of the questionnaire was distributed by e-mail to members registered to the KPBA.

Results

A total of 101 respondents completed the survey. Eighty respondents (79.2%) performed preoperative EUS-FNA/FNB for operable pancreatic solid mass. Acquire needles (60.4%) were used the most, followed by ProCore needles (47.5%). In terms of need size, most respondents (>80%) preferred 22-gauge needles regardless of the location of the mass. Negative suction with a 10-mL syringe (71.3%) as sampling technique was followed by stylet slow-pull (41.6%). More than three needle passes for EUS-FNA/FNB was performed by most respondents (>80%). The frequency of requiring repeated procedure was significantly higher in respondents with a low individual volume (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsVenous ThrombosisAntineoplastic AgentsHumansSorafenibPortal VeinTreatment OutcomeAntineoplastic Combined Chemotherapy Protocols

Substanzen

SorafenibAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

ORCID-Profile: Min Deng, Shaohua Li, Wei Wei, Rongping Guo

Zitieren

APA

Deng, M., Li, S., Wei, W., & Guo, R. (2023). Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver. https://doi.org/10.5009/gnl220249

Vancouver

Deng M, Li S, Wei W, Guo R. Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver. 2023. doi:10.5009/gnl220249

BibTeX
@article{Deng2023,
  author = {Deng, Min and Li, Shaohua and Wei, Wei and Guo, Rongping},
  title = {Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis},
  journal = {Gut and Liver},
  year = {2023},
  doi = {10.5009/gnl220249}
}
Kostenlos starten →